Pharmacogenetics: Clinical Trials

11 trials for Pharmacogenetics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 1 active not recruiting, 1 unknown. 11 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 6, Recruiting 2, Active not recruiting 1, Unknown 1, Withdrawn 1

Follow Pharmacogenetics: new trials by email Literature Review of Pharmacogenetics trials Research Report on Pharmacogenetics

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Evaluation of the Impact of Pharmacist Comprehensive Medication Management With Pharmacogenomic Results to Improve Depression Outcomes in Community Pharmacies.
Comprehensive medication management with PGx testing results, Usual Care - Pharmacogenetics, Depression - Major Depressive Disorder
Not applicableRecruitingUniversity of Pittsburgh2202026-09-092026-09-14
Pharmacogenomics-Supported Psychotropic Prescribing Trial
Pharmacogenetic Testing - Mental Disorder, Pharmacogenetics
Not applicableRecruitingUniversity of Manitoba2002025-07-012025-09-08
An Evaluation of the Impact of Pharmacist Personalized Medication Reviews With and Without a Discussion of Pharmacogenomic Results in an Employee Health Program.
Pharmacist Personalized Medication Review (PMR), Discussion of Pharmacogenomic results during the PMR - Pharmacogenetics, Pharmacogenomic Drug Interaction
Not applicableActive not recruitingUniversity of Pittsburgh6002025-01-152026-09-08
Perioperative Pharmacogenomic Testing
Pharmacogenomic optimisation of anaesthetic medications - Pharmacogenetics, Anesthesia
Not applicableUnknownPeter MacCallum Cancer Centre, Australia2002021-11-292023-05-23
Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans
Pharmacogenomic Screening - Pharmacogenetics, Depressive Disorder, Major
Not applicableWithdrawnAuburn University2021-09-012022-08-09
Individualized Antiretroviral Therapy
Pharmacogenomic index, Therapeutic drug monitoring - Pharmacogenetics, HIV
Not applicableCompletedHospital Italiano de Buenos Aires1902017-10-052025-09-09
Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care
acenocoumarol, control - Anticoagulant, Pharmacogenetics
Not applicableCompletedUniversidad San Jorge2042017-05-222021-05-04
Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting
Medication Therapy Management, Pharmacogenetic testing - Pharmacogenetics
Not applicableCompletedDuke University1902017-02-222021-06-03
The Implementation of Pharmacogenomics Into Primary Care in British Columbia
Decision support - Pharmacogenetics
Not applicableCompletedUniversity of British Columbia1902015-04-012015-12-18
Medication Therapy Management With Pharmacogenetic Testing
MTM with PGx - Pharmacogenetics, Medication Therapy Management
Not applicableCompletedDuke University302013-11-012015-04-20
Bioequivalence of Rebamipide in Korean
Rebamide - Therapeutic Equivalency, Pharmacogenetics
Not applicableCompletedChonnam National University Hospital302008-03-012009-10-19

Narrower conditions

Anxiety Disorders (1)  ·  Bipolar Disorder (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Mental Disorders (1)  ·  Pain, Postoperative (1)  ·  Psychological Well-Being (1)  ·  Psychotic Disorders (1)

Broader conditions

Mood Disorders (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Bipolar and Related Disorders (1)  ·  Chemically-Induced Disorders (1)  ·  Depressive Disorder (1)  ·  Mental Disorders (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Personal Satisfaction (1)  ·  Postoperative Complications (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Pharmacogenomic Testing (3)  ·  myotubularin (2)  ·  Acenocoumarol (1)  ·  Drug Monitoring (1)  ·  Medication Therapy Management (1)

Sponsors

Duke University (2)  ·  University of Pittsburgh (2)  ·  Auburn University (1)  ·  Chonnam National University Hospital (1)  ·  Hospital Italiano de Buenos Aires (1)  ·  Peter MacCallum Cancer Centre, Australia (1)  ·  Universidad San Jorge (1)  ·  University of British Columbia (1)  ·  University of Manitoba (1)

Countries

United States (5)  ·  Argentina (1)  ·  Australia (1)  ·  Canada (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Philip E Empey, PharmD, PhD (2)  ·  Abdullah Al Maruf, PhD, M.Pharm., B.Pharm (1)  ·  Kimberly B Lloyd, Pharm.D. (1)  ·  Susanne Haga, PhD (1)  ·  Waldo H Belloso, MD (1)  ·  Yong-Bok Lee, Ph.D. (1)

Results publications

PMID 20110013, PMID 27730116, PMID 37704534

NIH funding

R01GM081416 (1)